Testing a new automated insulin pump for people with diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new automated insulin delivery system (a pump that helps manage blood sugar) in children and adults with diabetes. It aims to see if the system is safe and easy to use in daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 7 and 85 years old (if you have type 1 diabetes) or between 18 and 85 years old (if you have type 2 diabetes).
- Have had type 1 diabetes for at least 6 months, or type 2 diabetes requiring insulin for at least 1 year.
- Be willing to wear the pump system continuously and upload its data using an app or computer.
- Have had a recent eye exam (as described) to check for diabetes-related eye issues.
- Be able to read English or Spanish, and be willing to give consent to participate.
- Be ready to use one of the specific rapid-acting insulins listed (like Humalog or Novolog).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests an insulin pump to help people with type 1 diabetes keep their blood sugar in a healthy range more of the time. You'll wear the pump and share weekly data with the study team.
This study tests a new experimental automated insulin delivery system for people with type 1 or type 2 diabetes who already use a specific insulin pump (MiniMed 780G with Simplera Sync sensor). The goal is to see if the new system is safe and works well to help manage blood sugar.
This study tests a new automated insulin pump system (NMX8) for adults with type 1 diabetes whose blood sugar is not well controlled (HbA1c above 7.5%). You must already be using a similar pump system. The goal is to see if this new device can help you get better control.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.